Click it and Unblock the Notifications
Biocon reports PAT of Rs 107 crore in H12007-08, Revenue Rs 553 cr
Bangalore,
Oct
18:
Reporting
a
27
per
cent
growth
in
net
profit,
biotech
major
Biocon
Limited
today
annmounced
a
revenue
of
Rs
553
crore
and
a
net
profit
of
Rs
107
crore
for
the
first
half
of
the
current
fiscal.
Consolidated Revenues grew by 19 per cent over the same period in the previous year. Research Services (Syngene) continued to deliver a robust dollar denominated growth of 60 per cent and an impressive 43 per cent based on Rupee realisation. Profit was restrained by rupee appreciation, the Company said in a release..
Biopharmaceuticals and branded formulations showed strong performance. Insulin was a significant contributor.
Technology and licensing revenues continued to contribute to H-1 financials.
The Company said its R and D expenditure increased to Rs 32 crore from Rs 19 crore in the previous year.
UNI
